EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dietary delivery of glycomacropeptide within the whey protein matrix is not effective in mitigating tissue ceramide deposition and obesity in mice fed a high-fat diet

Naomi M M P de Hart, Jonathan J Petrocelli, Rebekah J Nicholson, Elena M Yee, Lisha van Onselen, Marisa J Lang, Paul-Emile Bourrant, Patrick J Ferrara, Eric D Bastian, Loren S Ward, Brent L Petersen, Micah J Drummond

Journal of Dairy Science · 2024

DOI: 10.3168/jds.2023-23914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Dairy Science, 2024. Verfasst von Naomi M M P de Hart und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, UT 84112. Hauptthemen laut MEDLINE: Caseins, Glucose Intolerance, Insulin Resistance, Peptide Fragments. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is often accompanied by heightened circulating and tissue inflammation along with an increase in sphingolipids (e.g., ceramides) in metabolically active and insulin-sensitive organs. Whey protein isolate (WPI) has been shown to decrease inflammation and increase insulin sensitivity when given during a high-fat diet (HFD) intervention in rodents. The whey protein bioactive peptide glycomacropeptide (GMP) has also been linked to having anti-inflammatory properties and regulating lipogenesis. Therefore, the purpose of the study was to determine the effect of dietary GMP within the whey protein matrix on tissue inflammation, adiposity, and tissue ceramide accumulation in an obesogenic rodent model. Young adult male mice (10 wk old) underwent a 10-wk 60% HFD intervention. Glycomacropeptide was absent in the control low-fat diet and HFD WPI (-GMP) groups. The HFD WPI (1×GMP) treatment contained a standard amount of GMP, and HFD WPI (2×GMP) had double the amount. We observed no differences in weight gain or reductions in adiposity when comparing the GMP groups to HFD WPI (-GMP). Similarly, insulin resistance and glucose intolerance were not offset with GMP, and skeletal muscle and liver tissue ceramide content was unaltered with the GMP intervention. In contrast, the additional amount of GMP (2×GMP) might adversely affect tissue obesity-related pathologies. Together, dietary GMP given in a whey protein matrix during an HFD intervention does not alter weight gain, insulin resistance, glucose intolerance, and sphingolipid accumulation in the liver and skeletal muscle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaseinsGlucose IntoleranceInsulin ResistancePeptide FragmentsAnimalsMaleMiceCeramidesDiet, High-FatInflammationMice, Inbred C57BLObesitySphingolipidsWeight GainWhey Proteins

Stichwörter der Autor:innen

ceramideshigh-fat dietinflammationobesitywhey protein

Substanzen

caseinomacropeptideCaseinsCeramidesPeptide FragmentsSphingolipidsWhey Proteins

Autor:innen und Institutionen

  • Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, UT 84112.
  • Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, UT 84108.
  • Dairy West Innovation Partnerships, Twin Falls, ID 83301.
  • Glanbia Nutritionals Research, Twin Falls, ID 83301.
  • Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, UT 84112; Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, UT 84108. Electronic address: m…

Förderung

  • NIA NIH HHS
  • NIH HHS

Zitieren

APA

de Hart, N. M. M. P., Petrocelli, J. J., Nicholson, R. J., Yee, E. M., van Onselen, L., Lang, M. J., Bourrant, P. E., Ferrara, P. J., Bastian, E. D., Ward, L. S., Petersen, B. L., & Drummond, M. J. (2024). Dietary delivery of glycomacropeptide within the whey protein matrix is not effective in mitigating tissue ceramide deposition and obesity in mice fed a high-fat diet. Journal of Dairy Science. https://doi.org/10.3168/jds.2023-23914

Vancouver

de Hart NMMP, Petrocelli JJ, Nicholson RJ, Yee EM, van Onselen L, Lang MJ, et al. Dietary delivery of glycomacropeptide within the whey protein matrix is not effective in mitigating tissue ceramide deposition and obesity in mice fed a high-fat diet. Journal of Dairy Science. 2024. doi:10.3168/jds.2023-23914

BibTeX
@article{deHart2024,
  author = {de Hart, Naomi M M P and Petrocelli, Jonathan J and Nicholson, Rebekah J and Yee, Elena M and van Onselen, Lisha and Lang, Marisa J and Bourrant, Paul-Emile and Ferrara, Patrick J and Bastian, Eric D and Ward, Loren S and Petersen, Brent L and Drummond, Micah J},
  title = {Dietary delivery of glycomacropeptide within the whey protein matrix is not effective in mitigating tissue ceramide deposition and obesity in mice fed a high-fat diet},
  journal = {Journal of Dairy Science},
  year = {2024},
  doi = {10.3168/jds.2023-23914}
}
Kostenlos starten →